Outcomes in Patients Receiving Nintedanib or Pirfenidone for Idiopathic Pulmonary Fibrosis

被引：0
|
作者：
Cottin, V. [1 ,2 ,3 ,4 ]
Spagnolo, P. [5 ,6 ]
Bonniaud, P. [7 ,8 ]
Nolin, M. [9 ]
Dalon, F. [9 ]
Kirchgassler, K. [10 ]
Chia, J. [11 ]
Kamath, T. V. [11 ]
Van Ganse, E. [9 ,12 ,13 ,14 ]
Belhassen, M. [9 ]
机构：
[1] Louis Pradel Hosp, Natl Reference Coordinating Ctr Rare Pulm Dis, Lyon, France
[2] Hosp Civils Lyon, Lyon, France
[3] Univ Lyon, Univ Claude Bernard Lyon 1, UMR754, IVPC, F-69008 Lyon, France
[4] ERN LUNG, Lyon, France
[5] Univ Padua, Resp Dis Unit, Padua, Italy
[6] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Padua, Italy
[7] CHU Bourgogne, Ctr Reference Constitutif Malad Pulmonaires Rares, Serv Pneumol & Soins Intensifs Resp, Dijon, France
[8] Univ Bourgogne Franche Comte, Fac Med & Pharm, INSERM, U123 1, Dijon, France
[9] PELyon, PharmacoEpidemiol Lyon, Lyon, France
[10] F Hoffmann La Roche Ltd, Basel, Switzerland
[11] Genentech Inc, San Francisco, CA 94080 USA
[12] Univ Claude Bernard Lyon 1, Croix Rousse Univ Hosp, Resp Med, Lyon, France
[13] Univ Claude Bernard Lyon 1, EA7426, Lyon, France
[14] Univ Claude Bernard Lyon 1, Hlth Serv & Performance Res, HESPER 7425, Lyon, France
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1105
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Outcomes in patients receiving nintedanib or pirfenidone for idiopathic pulmonary fibrosis
    Cottin, Vincent
    Spagnolo, Paolo
    Bonniaud, Philippe
    Nolin, Maeva
    Dalon, Faustine
    Chia, Jenny
    Kirchgassler, Klaus
    Kamath, Tripthi
    Van Ganse, Eric
    Belhassen, Manon
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 121 - 121
  • [2] Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
    Belhassen, Manon
    Dalon, Faustine
    Nolin, Maeva
    Van Ganse, Eric
    [J]. RESPIRATORY RESEARCH, 2021, 22 (01)
  • [3] Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
    Manon Belhassen
    Faustine Dalon
    Maëva Nolin
    Eric Van Ganse
    [J]. Respiratory Research, 22
  • [4] Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis
    Sathiyamoorthy, Gayathri
    Sehgal, Sameep
    Ashton, Rendell W.
    [J]. SOUTHERN MEDICAL JOURNAL, 2017, 110 (06) : 393 - 398
  • [5] SAFETY OF COMBINED PIRFENIDONE AND NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Flaherty, K. R.
    Fell, C. D.
    Huggins, J. T.
    Nunes, H.
    Sussman, R.
    Valenzuela, C.
    Petzinger, U.
    Stauffer, J. L.
    Gilberg, F.
    Bengus, M.
    Wijsenbeek, M.
    [J]. THORAX, 2017, 72 : A253 - A254
  • [6] Healthcare resource use and related costs in patients receiving nintedanib or pirfenidone for idiopathic pulmonary fibrosis
    Bonniaud, Philippe
    Cottin, Vincent
    Spagnolo, Paolo
    Nolin, Maeva
    Dalon, Faustine
    Kirchgassler, Klaus-Uwe
    Chia, Jenny
    Kamath, Tripthi
    Van Ganse, Eric
    Belhassen, Manon
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [7] Healthcare resource use and associated costs in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
    Cottin, Vincent
    Spagnolo, Paolo
    Bonniaud, Philippe
    Dalond, Faustine
    Nolind, Maeva
    Kirchgassler, Klaus-Uwe
    Van Ganse, Eric
    Belhassen, Manon
    [J]. RESPIRATORY MEDICINE AND RESEARCH, 2023, 83
  • [8] Comparative Effectiveness of Nintedanib and Pirfenidone in Patients Diagnosed With Idiopathic Pulmonary Fibrosis
    Shankar, D.
    Law, A.
    Walkey, A. J.
    Hawkins, F. J.
    Alysandratos, K.
    Wilson, K. C.
    Bosch, N. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [9] Adoption of the Antifibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary Fibrosis
    Dempsey, Timothy M.
    Payne, Stephanie
    Sangaralingham, Lindsey
    Yao, Xiaoxi
    Shah, Nilay D.
    Limper, Andrew H.
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1121 - 1128
  • [10] Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
    Ogura, Takashi
    Taniguchi, Hiroyuki
    Azuma, Arata
    Inoue, Yoshikazu
    Kondoh, Yasuhiro
    Hasegawa, Yoshinori
    Bando, Masashi
    Abe, Shinji
    Mochizuki, Yoshiro
    Chida, Kingo
    Klueglich, Matthias
    Fujimoto, Tsuyoshi
    Okazaki, Kotaro
    Tadayasu, Yusuke
    Sakamoto, Wataru
    Sugiyama, Yukihiko
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (05) : 1382 - 1392
12345